 | • レポートコード：QYR9ST04962 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ナノ抗体の世界市場について調査・分析し、ナノ抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（一価ナノボディ、多価及び多重特異性ナノボディ、融合ナノボディ）、用途別（生体外での疾患検出、生体内での非侵襲的診断、腫瘍標的療法、神経系疾患、循環器疾患、感染症、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のナノ抗体市場動向 ・主要企業別マーケットシェア ・ナノ抗体の種類別市場規模2014-2019 （一価ナノボディ、多価及び多重特異性ナノボディ、融合ナノボディ） ・ナノ抗体の用途別市場規模2014-2019 （生体外での疾患検出、生体内での非侵襲的診断、腫瘍標的療法、神経系疾患、循環器疾患、感染症、その他） ・ナノ抗体の北米市場：主要企業・種類別/用途別市場規模 ・ナノ抗体のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ナノ抗体の中国市場：主要企業・種類別/用途別市場規模 ・ナノ抗体の日本国内市場：主要企業・種類別/用途別市場規模 ・ナノ抗体の東南アジア市場：主要企業・種類別/用途別市場規模 ・ナノ抗体のインド市場：主要企業・種類別/用途別市場規模 ・ナノ抗体の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Ablynx、PREGENE、Alphamab、PersonGen） ・ナノ抗体の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Nanoantibodies or “nAb” are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages:
Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability
In 2018, the global Nano Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Nano Antibodies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nano Antibodies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Ablynx
PREGENE
Alphamab
PersonGen
…
Market segment by Type, the product can be split into
Monovalent Nanobody
Multivalent and multispecific Nanobodies
Fusion Nanobody
Market segment by Application, split into
Disease detection in vitro
Non-invasive diagnosis in vivo
Tumor targeted therapy
Nervous system disease
Circulatory disease
Infectious disease
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Nano Antibodies status, future forecast, growth opportunity, key market and key players.
To present the Nano Antibodies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Nano Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nano Antibodies Market Size Growth Rate by Type (2014-2025)
1.4.2 Monovalent Nanobody
1.4.3 Multivalent and multispecific Nanobodies
1.4.4 Fusion Nanobody
1.5 Market by Application
1.5.1 Global Nano Antibodies Market Share by Application (2019-2025)
1.5.2 Disease detection in vitro
1.5.3 Non-invasive diagnosis in vivo
1.5.4 Tumor targeted therapy
1.5.5 Nervous system disease
1.5.6 Circulatory disease
1.5.7 Infectious disease
1.5.8 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Nano Antibodies Market Size
2.2 Nano Antibodies Growth Trends by Regions
2.2.1 Nano Antibodies Market Size by Regions (2019-2025)
2.2.2 Nano Antibodies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Nano Antibodies Market Size by by Players
3.1.1 Global Nano Antibodies Revenue by by Players (2014-2019)
3.1.2 Global Nano Antibodies Revenue Market Share by by Players (2014-2019)
3.1.3 Global Nano Antibodies Market Concentration Ratio (CR5 and HHI)
3.2 Nano Antibodies Key Players Head office and Area Served
3.3 Key Players Nano Antibodies Product/Solution/Service
3.4 Date of Enter into Nano Antibodies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Nano Antibodies Market Size by Type (2014-2019)
4.2 Global Nano Antibodies Market Size by Application (2014-2019)
5 North America
5.1 North America Nano Antibodies Market Size (2014-2019)
5.2 Nano Antibodies Key Players in North America
5.3 North America Nano Antibodies Market Size by Type
5.4 North America Nano Antibodies Market Size by Application
6 Europe
6.1 Europe Nano Antibodies Market Size (2014-2019)
6.2 Nano Antibodies Key Players in Europe
6.3 Europe Nano Antibodies Market Size by Type
6.4 Europe Nano Antibodies Market Size by Application
7 China
7.1 China Nano Antibodies Market Size (2014-2019)
7.2 Nano Antibodies Key Players in China
7.3 China Nano Antibodies Market Size by Type
7.4 China Nano Antibodies Market Size by Application
8 Japan
8.1 Japan Nano Antibodies Market Size (2014-2019)
8.2 Nano Antibodies Key Players in Japan
8.3 Japan Nano Antibodies Market Size by Type
8.4 Japan Nano Antibodies Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Nano Antibodies Market Size (2014-2019)
9.2 Nano Antibodies Key Players in Southeast Asia
9.3 Southeast Asia Nano Antibodies Market Size by Type
9.4 Southeast Asia Nano Antibodies Market Size by Application
10 India
10.1 India Nano Antibodies Market Size (2014-2019)
10.2 Nano Antibodies Key Players in India
10.3 India Nano Antibodies Market Size by Type
10.4 India Nano Antibodies Market Size by Application
11 Central & South America
11.1 Central & South America Nano Antibodies Market Size (2014-2019)
11.2 Nano Antibodies Key Players in Central & South America
11.3 Central & South America Nano Antibodies Market Size by Type
11.4 Central & South America Nano Antibodies Market Size by Application
12 International Players Profiles
12.1 Ablynx
12.1.1 Ablynx Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nano Antibodies Introduction
12.1.4 Ablynx Revenue in Nano Antibodies Business (2014-2019))
12.1.5 Ablynx Recent Development
12.2 PREGENE
12.2.1 PREGENE Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nano Antibodies Introduction
12.2.4 PREGENE Revenue in Nano Antibodies Business (2014-2019)
12.2.5 PREGENE Recent Development
12.3 Alphamab
12.3.1 Alphamab Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nano Antibodies Introduction
12.3.4 Alphamab Revenue in Nano Antibodies Business (2014-2019)
12.3.5 Alphamab Recent Development
12.4 PersonGen
12.4.1 PersonGen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nano Antibodies Introduction
12.4.4 PersonGen Revenue in Nano Antibodies Business (2014-2019)
12.4.5 PersonGen Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Nano Antibodies Key Market Segments
Table Key Players Nano Antibodies Covered
Table Global Nano Antibodies Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Monovalent Nanobody Figures
Table Key Players of Monovalent Nanobody
Figuer Multivalent and multispecific Nanobodies Figures
Table Key Players of Multivalent and multispecific Nanobodies
Figuer Fusion Nanobody Figures
Table Key Players of Fusion Nanobody
Table Global Nano Antibodies Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Nano Antibodies Market Share by Application in 2018 & 2025
Figure Disease detection in vitro Case Studies
Figure Non-invasive diagnosis in vivo Case Studies
Figure Tumor targeted therapy Case Studies
Figure Nervous system disease Case Studies
Figure Circulatory disease Case Studies
Figure Infectious disease Case Studies
Figure Other Case Studies
Figure Nano Antibodies Report Years Considered
Figure Global Nano Antibodies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nano Antibodies Market Size by Regions 2019-2025 (Million US$)
Table Global Nano Antibodies Market Size by Regions 2019-2025 (Million US$)
Table Global Nano Antibodies Market Share by Regions 2014-2019
Figure Global Nano Antibodies Market Share by Regions 2014-2019
Figure Global Nano Antibodies Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Nano Antibodies Revenue by by Players (2014-2019) (Million US$)
Table Global Nano Antibodies Market Share by by Players (2014-2019)
Figure Global Nano Antibodies Market Share by by Players in 2018
Table Global Nano Antibodies by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nano Antibodies Product/Solution/Service
Table Date of Enter into Nano Antibodies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nano Antibodies Market Size by Type (2014-2019) (Million US$)
Table Global Nano Antibodies Market Size Share by Type (2014-2019)
Figure Global Nano Antibodies Market Size Market Share by Type (2014-2019)
Table Global Nano Antibodies Market Size by Application (2014-2019) (Million US$)
Table Global Nano Antibodies Market Size Share by Application (2014-2019)
Figure Global Nano Antibodies Market Size Market Share by Application (2014-2019)
Figure Global Nano Antibodies Revenue Market Share by Application in 2018
Figure North America Nano Antibodies Market Size 2014-2019 (Million US$)
Table North America Key Players Nano Antibodies Revenue (2018-2019) (Million US$)
Table North America Key Players Nano Antibodies Market Share (2018-2019)
Table North America Nano Antibodies Market Size by Type 2014-2019 (Million US$)
Table North America Nano Antibodies Market Share by Type 2014-2019
Table North America Nano Antibodies Market Size by Application 2014-2019 (Million US$)
Table North America Nano Antibodies Market Share by Application 2014-2019
Figure Europe Nano Antibodies Market Size 2014-2019 (Million US$)
Table Europe Key Players Nano Antibodies Revenue (2018-2019) (Million US$)
Table Europe Key Players Nano Antibodies Market Share (2018-2019)
Table Europe Nano Antibodies Market Size by Type 2014-2019 (Million US$)
Table Europe Nano Antibodies Market Share by Type 2014-2019
Table Europe Nano Antibodies Market Size by Application 2014-2019 (Million US$)
Table Europe Nano Antibodies Market Share by Application 2014-2019
Figure China Nano Antibodies Market Size 2014-2019 (Million US$)
Table China Key Players Nano Antibodies Revenue (2018-2019) (Million US$)
Table China Key Players Nano Antibodies Market Share (2018-2019)
Table China Nano Antibodies Market Size by Type 2014-2019 (Million US$)
Table China Nano Antibodies Market Share by Type 2014-2019
Table China Nano Antibodies Market Size by Application 2014-2019 (Million US$)
Table China Nano Antibodies Market Share by Application 2014-2019
Figure Japan Nano Antibodies Market Size 2014-2019 (Million US$)
Table Japan Key Players Nano Antibodies Revenue (2018-2019) (Million US$)
Table Japan Key Players Nano Antibodies Market Share (2018-2019)
Table Japan Nano Antibodies Market Size by Type 2014-2019 (Million US$)
Table Japan Nano Antibodies Market Share by Type 2014-2019
Table Japan Nano Antibodies Market Size by Application 2014-2019 (Million US$)
Table Japan Nano Antibodies Market Share by Application 2014-2019
Figure Southeast Asia Nano Antibodies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nano Antibodies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nano Antibodies Market Share (2018-2019)
Table Southeast Asia Nano Antibodies Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Nano Antibodies Market Share by Type 2014-2019
Table Southeast Asia Nano Antibodies Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Nano Antibodies Market Share by Application 2014-2019
Figure India Nano Antibodies Market Size 2014-2019 (Million US$)
Table India Key Players Nano Antibodies Revenue (2018-2019) (Million US$)
Table India Key Players Nano Antibodies Market Share (2018-2019)
Table India Nano Antibodies Market Size by Type 2014-2019 (Million US$)
Table India Nano Antibodies Market Share by Type 2014-2019
Table India Nano Antibodies Market Size by Application 2014-2019 (Million US$)
Table India Nano Antibodies Market Share by Application 2014-2019
Figure Central & South America Nano Antibodies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nano Antibodies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nano Antibodies Market Share (2018-2019)
Table Central & South America Nano Antibodies Market Size by Type 2014-2019 (Million US$)
Table Central & South America Nano Antibodies Market Share by Type 2014-2019
Table Central & South America Nano Antibodies Market Size by Application 2014-2019 (Million US$)
Table Central & South America Nano Antibodies Market Share by Application 2014-2019
Table Ablynx Company Details
Table Ablynx Revenue in Nano Antibodies Business 2014-2019 (Million US$)
Figure Ablynx Revenue Growth Rate in Nano Antibodies Business (2014-2019)
Table Ablynx Recent Development
Table PREGENE Company Details
Table PREGENE Revenue in Nano Antibodies Business 2014-2019 (Million US$)
Figure PREGENE Revenue Growth Rate in Nano Antibodies Business (2014-2019)
Table PREGENE Recent Development
Table Alphamab Company Details
Table Alphamab Revenue in Nano Antibodies Business 2014-2019 (Million US$)
Figure Alphamab Revenue Growth Rate in Nano Antibodies Business (2014-2019)
Table Alphamab Recent Development
Table PersonGen Company Details
Table PersonGen Revenue in Nano Antibodies Business 2014-2019 (Million US$)
Figure PersonGen Revenue Growth Rate in Nano Antibodies Business (2014-2019)
Table PersonGen Recent Development
Table Global Nano Antibodies Market Size by Regions (Million US$) 2019-2025
Figure Global Nano Antibodies Market Size Share by Regions (2019-2025)
Figure Global Nano Antibodies Market Size Share by Regions in 2025
Figure North America Nano Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nano Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure China Nano Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nano Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nano Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure India Nano Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nano Antibodies Market Size Forecast (2019-2025)(Million USD)
Table Global Nano Antibodies Market Size by Product (2019-2025) (Million US$)
Figure Global Nano Antibodies Market Size by Product (2019-2025)
Figure Global Nano Antibodies Market Size by Product in 2025
Table Global Nano Antibodies Market Size by Application (2019-2025) (Million US$)
Figure Global Nano Antibodies Market Size by Application (2019-2025)
Figure Global Nano Antibodies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
HER2抗体の世界市場：市場規模・現状・予測 The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer. In 2018, the global HER2 Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% duri…- 組換え治療用抗体及びタンパク質の世界市場：インサイト・予測 Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- 神経科抗体及びアッセイの世界市場：市場規模・現状・予測 The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.In 2018, the global Neuroscience Antibodies and Assays market size was…
- 乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…
- 世界の小分子抗体市場：専門的調査 Antibodies against small molecules constitute an easy, fast and cost-efficient alternative to HPLC and mass spectrometry when it comes to small molecule detection. The global Small Molecule Antibodies market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growi…